Rockwell Medical Secures Major Deal to Supply Dialysis Products for At-Home and Acute Care
Rockwell Medical Secures Major Deal to Supply Dialysis Products for At-Home and Acute Care
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced a product purchase agreement with the leading at-home and acute care dialysis provider in the United States (the "Customer"). Under the terms of the agreement, Rockwell Medical will supply the Customer with the Company's liquid acid RenalPure and liquid bicarbonate SteriLyte, both of which will be packaged in either the Company's four-per-case packaging for larger dialysis settings or two-per-case packaging for smaller acute care and at-home care settings.
Rockwell Medical公司（"公司"）（納斯達克：RMTI），一家開發、生產、商業化並向世界各地的透析服務提供商分銷透析產品組合的醫療保健公司，今天宣佈與美國領先的家庭和急性護理透析服務提供商（"客戶"）簽訂產品採購協議。根據協議條款，Rockwell Medical將向客戶供應公司的液體酸性透析液RenalPure和液體碳酸氫根透析液SteriLyte，這兩種產品將分別包裝在公司的每箱四袋的大型透析場所包裝或每箱兩袋的較小急性護理和家庭護理場所包裝中。
譯文內容由第三人軟體翻譯。